Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)along with tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, have transformed the management of type 2 diabetes and obesity
Furthermore, it should not be used by people with hypersensitivity to this amino acid or any other component of the medicine
We dont have nonsurgical therapies that directly target cardiovascular risk-associated overweight or obesity and the related metabolic abnormalities
It happens because the medication slows gastric emptying, which can cause feelings of queasiness or upset stomach
Individuals with ADHD are often found to have low vitamin D levels as well (47)